Navigation Links
Cardium Selected for Inclusion in Russell Microcap Index
Date:6/24/2008

SAN DIEGO, June 24 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) announced today that it has been selected for inclusion in the Russell Microcap Index, according to the preliminary list of additions issued by the Russell Investment Group. The 2008 reconstitution of the Russell Indexes will take place after the market close on June 27, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

Annual reconstitution of Russell's U.S. indices captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. Russell determines membership for its equity indices primarily by objective market-capitalization rankings and style attributes.

"The addition to the Russell Microcap Index represents another step forward for Cardium. Inclusion in the index offers the potential to broaden our exposure to institutional investors and portfolio managers," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications. Cardium's lead product candidate, Generx(TM) (alferminogene tadenovec, Ad5FGF4), is a DNA-based growth factor therapeutic being developed for potential use by interventional cardiologists as a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of patients with ischemic conditions such as recurrent
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
2. Cardium Launches New AWARE Clinical Study Website
3. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
4. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
5. Cardium Reports on First Quarter 2008 Highlights and Financial Results
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
8. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
9. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
10. Cardium Completes $5.3 Million Registered Direct Offering
11. Cardium Announces $5.3 Million Registered Direct Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...STER, Germany, November 19 MONITOR...ovember 16th, 2009 Flibanserin in the,indication t...arkinson,s,disease for orphan drug status designat...odopa-induced dyskinesia is a complication of the ...erious burden to some of those,affected, since it ...
(Date:11/19/2009)...ENNA, Austria, November 19 AFFiRiS...one product candidate at an unexpectedly early,sta...lanned to enter into,Phase II clinical trial early... follows the completion of two Phase I trials with...ts fast decision on the first interim,analysis of ...
(Date:11/18/2009)...,s University Belfast are developing new sensors t...ill help in the fight against the threat of terror...pads to ,swipe, an individual or crime scene to ga... instrument that can detect the presence of chemic... decisions to be made in response to terrorist thr...
(Date:11/18/2009)...ORK, Nov. 18 Reportlinker.com anno...le in its catalogue. ,, Biotechnology Reagent...ww.reportlinker.com/p0164375/Biotechnology-Reagent...newswire&utm_medium=pr&utm_campaign=prnews...mplex chemical compounds used in a range of biotec...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8
...d for DNA-Guided Decision Support in Diabetes Drug...y Genomas has shown statistically significant asso...athways to body mass index (BMI) and edema (fluid ...e (TZD) drugs pioglitazone and rosiglitazone. The ...Diabetes Center Affiliate at The Hospital of Centr...
...many and STOCKHOLM, January 21 Richter-Helm,BioLo...AB have signed an,agreement for the development an...ention of plaque rupture and athero-thrombosis thr...elium. The recombinant protein Annexin A5 is,inten...ary Syndrome and who,are at imminent risk for Myoc...
...0 Immtech Pharmaceuticals, Inc. (NYSE Alternext U...pointed Virchow, Krause & Company, LLP as its ...ective immediately. The decision to change the Com...rm was approved by the Company,s board of director...r Immtech. , , Virchow Krause is the nation,s 17...
Other Biology Technology:Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study 2Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease 2Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease 3Immtech Announces Appointment of Virchow Krause as Independent Registered Public Accounting Firm 2
(Date:11/22/2009)...m of pioneering South Korean scientists have succe...lastics through bioengineering, rather than throug...undbreaking research, which may now allow for the ...is published in two papers in the journal Biotech...0th anniversary. , Polymers are molecules found...
(Date:11/22/2009)...HINGTON, D.C. November 18, 2009 -- A butterfly,s p...used for sipping -- but it works more like a paper...University. He hopes to borrow the tricks of this ...can sample the fluid inside of cells. , Kornev w...Meeting of the American Physical Society,s (APS) D...
(Date:11/21/2009)...ried, Germany, November 20,2009 / b3c newswire /...letion of a financing round, gaining two new inves... the same time KINAXO reports that Jrgen Schumache... advisory board. , KINAXO shareholders Axel Ullr...he companys institutional investors Mountain Partn...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3American Society of Plastic Surgeons Annual Meeting Photo Op 59290 1American Society of Plastic Surgeons Annual Meeting Photo Op 59290 2American Society of Plastic Surgeons Annual Meeting Photo Op 59290 3Physicians Gain Visibility Control Over Data With Sage Practice Analytics 59287 1Physicians Gain Visibility Control Over Data With Sage Practice Analytics 59287 2Sudden Cardiac Arrest Association Honors FDNYs Department of Emergency Services for Efforts to Address Sudden Cardiac Arrest 59284 1Sudden Cardiac Arrest Association Honors FDNYs Department of Emergency Services for Efforts to Address Sudden Cardiac Arrest 59284 2
...7 The American Chemical Society (ACS) today prais... federal coordination, dissemination and investmen...). The Green Chemistry Research and Development Ac...stainable technological options to replace traditi...roduced in the House on June 25, 2007, by Reps. Ph...
...rsity of Colorado at Boulder indicates biologists ...at trout from extinction over the past several dec...fforts have, in most cases, inadvertently restored...NA analysis, five of nine "relic" populations of w...trout living in isolated pockets of the state actu...
...e useful in predicting the level of aggression of ...d follow-up care, according to new study findings.... alteration in the BRAF oncogene, a modified gene ...rted in the September issue of the Annals of Surge...requently occurs in the most common type of thyroi...
Other Biology News:American Chemical Society calls green chemistry bill a 'smart step' 2New study shows greenback cutthroat trout involved in recovery effort misidentified 2New study shows greenback cutthroat trout involved in recovery effort misidentified 3Presence of gene mutation helps guide thyroid cancer treatment 2Presence of gene mutation helps guide thyroid cancer treatment 3
...rmation can be difficult to achieve in many bacter...triction and modification (R-M) systems that cleav...TypeOne™ Restriction Inhibitor provides a pow...ncies in bacterial strains with type I R-M systems...
Pyronin Y from Sigma-Aldrich
Agencourt AMPure 60ml Kit from Agencourt Bioscience
Agencourt AMPure 384 Starter Kit from Agencourt Bioscience
Biology Products: